Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Animal data suggest that GPI-1046 may be useful in glaucoma

Nov. 18, 1998

New prostaglandins with IOP-lowering effects disclosed by Santen and Asahi Glass

Nov. 16, 1998

Final results presented from phase II Vitrase trial

Nov. 13, 1998

Significant antiinflammatory activity seen with loteprednol etabonate in cataract surgery setting

Nov. 5, 1998

Vitrase to be fast-tracked by FDA

Oct. 16, 1998

Long-acting fluorine-containing prostaglandins for ocular diseases

Oct. 7, 1998

Phase II trial commences of AG-3340 in AMD

Sep. 17, 1998

Phase II testing of ISV-205 begins for glaucoma

Sep. 14, 1998

Micrologix Biotech advances development of antimicrobial peptides for treatment of eye infections

Sep. 14, 1998

Troponin I blocks retinal angiogenesis in another animal model

Sep. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...